Literature DB >> 1671806

Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome.

G K Suthers1, J C Mulley, M A Voelckel, N Dahl, M L Väisänen, P Steinbach, I A Glass, C E Schwartz, B A van Oost, S N Thibodeau.   

Abstract

The fragile X syndrome is the most common cause of familial mental retardation and is characterized by a fragile site at the end of the long arm of the X chromosome. The unusual genetics and cytogenetics of this X-linked condition make genetic counseling difficult. DNA studies were of limited value in genetic counseling, because the nearest polymorphic DNA loci had recombination fractions of 12% or more with the fragile X mutation, FRAXA. Five polymorphic loci have recently been described in this region of the X chromosome. The positions of these loci in relation to FRAXA were defined in a genetic linkage study of 112 affected families. The five loci--DXS369, DXS297, DXS296, IDS, and DXS304--had recombination fractions of 4% or less with FRAXA. The closest locus, DXS296, was distal to FRAXA and had a recombination fraction of 2%. The polymorphisms at these loci can be detected in DNA enzymatically digested with a limited number of restriction endonucleases. A strategy for DNA studies which is based on three restriction endonucleases and on five probes will detect one or more of these polymorphisms in 94% of women. This strategy greatly increases the utility of DNA studies in providing genetic advice to families with the fragile X syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671806      PMCID: PMC1682966     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  New polymorphic DNA marker close to the fragile site FRAXA.

Authors:  B A Oostra; P E Hupkes; L F Perdon; C A van Bennekom; E Bakker; D J Halley; M Schmidt; D Du Sart; A Smits; B Wieringa
Journal:  Genomics       Date:  1990-01       Impact factor: 5.736

2.  New informative polymorphism at the DXS304 locus, a close distal marker for the fragile X locus.

Authors:  F Rousseau; A Vincent; I Oberlé; J L Mandel
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

3.  A BclI RFLP for DXS296 (VK21) near the fragile X.

Authors:  S Yu; G K Suthers; J C Mulley
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

4.  Efficient computations in multilocus linkage analysis.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

5.  Multilocus analysis of the fragile X syndrome.

Authors:  W T Brown; A Gross; C Chan; E C Jenkins; J L Mandel; I Oberlé; B Arveiler; G Novelli; S Thibodeau; R Hagerman
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

6.  Preventive screening for the fragile X syndrome.

Authors:  G Turner; H Robinson; S Laing; S Purvis-Smith
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

7.  Recurrence risks for relatives in families with an isolated case of the fragile X syndrome.

Authors:  S L Sherman; A Rogatko; G Turner
Journal:  Am J Med Genet       Date:  1988-12

8.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males.

Authors:  S L Sherman; P A Jacobs; N E Morton; U Froster-Iskenius; P N Howard-Peebles; K B Nielsen; M W Partington; G R Sutherland; G Turner; M Watson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

10.  The common fragile site in band q27 of the human X chromosome is not coincident with the fragile X.

Authors:  G R Sutherland; E Baker
Journal:  Clin Genet       Date:  1990-03       Impact factor: 4.438

View more
  15 in total

1.  Estimating the stability of the proposed imprinted state of the fragile-X mutation when transmitted by females.

Authors:  P J Follette; C D Laird
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

Review 2.  Molecular analysis of the fragile X syndrome.

Authors:  M C Hirst; S M Knight; Y Nakahori; A Roche; K E Davies
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers.

Authors:  R I Richards; Y Shen; K Holman; H Kozman; V J Hyland; J C Mulley; G R Sutherland
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome.

Authors:  D Wöhrle; D Kotzot; M C Hirst; A Manca; B Korn; A Schmidt; G Barbi; H D Rott; A Poustka; K E Davies
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 5.  X linked mental retardation.

Authors:  I A Glass
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

6.  Fragile-X syndrome: unique genetics of the heritable unstable element.

Authors:  S Yu; J Mulley; D Loesch; G Turner; A Donnelly; A Gedeon; D Hillen; E Kremer; M Lynch; M Pritchard
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

7.  Difficult diagnosis of the fragile X syndrome made possible by direct detection of DNA mutations.

Authors:  J Tarleton; S Wong; D Heitz; C Schwartz
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

8.  Isolation of a human DNA sequence which spans the fragile X.

Authors:  E J Kremer; S Yu; M Pritchard; R Nagaraja; D Heitz; M Lynch; E Baker; V J Hyland; R D Little; M Wada
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

9.  Molecular carrier testing for the fragile X syndrome: Issues for genetic counselors.

Authors:  J L Berliner; F N Shapiro; S L Nolin; G E Houck; X H Ding; C Dobkin; S S Brooks; W T Brown
Journal:  J Genet Couns       Date:  1994-09       Impact factor: 2.537

10.  Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.

Authors:  W Schröder; L Petruschka; M Wehnert; M Zschiesche; G Seidlitz; J J Hopwood; F H Herrmann
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.